About Ingevity (NYSE:NGVT)
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Industry, Sector and Symbol
Industry Chemicals & allied products
Trailing P/E Ratio31.94
Forward P/E Ratio23.97
Sales & Book Value
Annual Sales$972.40 million
Price / Sales3.59
Cash Flow$3.5750 per share
Price / Cash23.20
Book Value$6.60 per share
Price / Book12.57
EPS (Most Recent Fiscal Year)$2.58
Net Income$126.50 million
Return on Equity48.09%
Return on Assets12.37%
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity Corp (NYSE:NGVT) posted its quarterly earnings data on Wednesday, May, 2nd. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.16. The firm had revenue of $235.20 million for the quarter, compared to the consensus estimate of $231.76 million. Ingevity had a return on equity of 48.09% and a net margin of 13.96%. The business's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.49 EPS. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
What price target have analysts set for NGVT?
8 equities research analysts have issued 1-year target prices for Ingevity's shares. Their forecasts range from $67.00 to $92.00. On average, they anticipate Ingevity's stock price to reach $86.3750 in the next year. View Analyst Ratings for Ingevity.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include FMC (FMC), JOHNSON MATTHEY/S (JMPLY), Chemours (CC), Huntsman (HUN), Olin (OLN), W. R. Grace & Co (GRA), Ashland Global (ASH), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), Innospec (IOSP), KMG Chemicals (KMG), OCI Partners (OCIP) and Innophos (IPHS).
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57)
Has Ingevity been receiving favorable news coverage?
Media stories about NGVT stock have been trending somewhat positive on Monday, according to Accern. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Ingevity earned a coverage optimism score of 0.05 on Accern's scale. They also assigned media headlines about the company an impact score of 47.46 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
Who are Ingevity's major shareholders?
Ingevity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.20%), Franklin Resources Inc. (4.09%), Chilton Investment Co. LLC (2.27%), Silvercrest Asset Management Group LLC (2.22%), Massachusetts Financial Services Co. MA (2.05%) and Loomis Sayles & Co. L P (1.78%). View Institutional Ownership Trends for Ingevity.
Which institutional investors are selling Ingevity stock?
NGVT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Royal Bank of Canada, Millennium Management LLC, Silvercrest Asset Management Group LLC, Wells Fargo & Company MN, Loomis Sayles & Co. L P, Chilton Investment Co. LLC and Mesirow Financial Investment Management Equity Management. View Insider Buying and Selling for Ingevity.
Which institutional investors are buying Ingevity stock?
NGVT stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Palisade Capital Management LLC NJ, BlackRock Inc., Prudential Financial Inc., Dimensional Fund Advisors LP, OppenheimerFunds Inc., Natixis Advisors L.P. and Old Mutual Global Investors UK Ltd.. View Insider Buying and Selling for Ingevity.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $82.94.
How big of a company is Ingevity?
Ingevity has a market capitalization of $3.49 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.
How can I contact Ingevity?
Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NGVT)MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.